Loading clinical trials...

Pregnancy, Anti-integrase and Lymphocyte Repertoire of the Newborn | Clinical Trials | Clareo Health

COMPLETEDNCT04024150

Pregnancy, Anti-integrase and Lymphocyte Repertoire of the Newborn

The objective of the study is to evaluate at birth, the diversity of the T repertoire of newborns exposed in utero to anti-integrases in comparison with a control group of children exposed to other an...

Lead sponsor: Assistance Publique - Hôpitaux de Paris•5 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment29

Start dateDec 2019

Last updatedMar 9, 2026

Condition

Anti-integrases

Locations shown

AP-HP, Hôpital Louis Mourier

Colombes

AP-HP, Hôpital de la Pitié Salpêtrière

Paris

AP-HP, Hôpital Cochin

Paris

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 9, 2026Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions